Reliability of the Facial Wrinkle Scale in Japanese Subjects

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Allergan

ClinicalTrials.gov Identifier:

NCT01600729

First received: May 15, 2012

Last updated: July 10, 2012

Last verified: July 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

May 15, 2012

Last Updated Date

July 10, 2012

Start Date ^ICMJE

June 2012

Primary Completion Date

July 2012 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Inter-rater Reliability of Assessment of Facial Lines Using the 4-Point FWS-A [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
Intra-rater Reliability of Assessment of Facial Lines Using the 4-Point FWS-A [ Time Frame: Day 1 ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT01600729 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Independent Photographic Raters' Assessment of Facial Lines Using the 4-Point FWS-A [ Time Frame: Day 1 ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Reliability of the Facial Wrinkle Scale in Japanese Subjects

Official Title ^ICMJE

Not Provided

Brief Summary

This study will evaluate the inter-rater and intra-rater reliability of the Facial Wrinkle Scale with Asian Photonumeric Guide (FWS-A) in Japanese subjects.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Cohort
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

Subjects with facial lines

Condition ^ICMJE

Facial Rhytides

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Subjects with Facial Lines

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

July 2012

Primary Completion Date

July 2012 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Ability to assess facial lines in a mirror
Removal of facial jewelry and makeup for study visit

Exclusion Criteria:

Infection or skin disorder affecting the face
Planned use of botulinum toxin of any serotype between Screening and Day 1
Planned facial cosmetic procedure between Screening and Day 1
Planned excessive/prolonged sun exposure between Screening and Day 1

Gender

Both

Ages

20 Years to 64 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Japan

Administrative Information

NCT Number ^ICMJE

NCT01600729

Other Study ID Numbers ^ICMJE

191622-119

Has Data Monitoring Committee

Responsible Party

Allergan

Study Sponsor ^ICMJE

Allergan

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Director:

Medical Director

Allergan

Information Provided By

Allergan

Verification Date

July 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top